insights_auto
Why is AMGN34 down 2,76%?
Dive Deeperchevron_right
AMGN34:BVMF
Amgen Inc. BDR
R$78,80
arrow_downward
-2,76%(-2,24) 1D
23 ຕ.ລ., 16 ໂມງ 56 ນາທີ 00 ວິນາທີ GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMGN34...
Open
R$79,52
High
R$79,52
Low
R$78,80
Mkt. cap
237,48 ຕື້
Avg. vol.
395,00
Volume
0,00
52-wk high
R$83,06
52-wk low
R$47,76
Shares outstanding
540,63 ລ້ານ
No. of employees
32 ພັນ
Open
R$79,52
High
R$79,52
Low
R$78,80
Mkt. cap
237,48 ຕື້
Avg. vol.
395,00
Volume
0,00
52-wk high
R$83,06
52-wk low
R$47,76
Shares outstanding
540,63 ລ້ານ
No. of employees
32 ພັນ
News stories
From web sources and news partners
Yahoo Finance
·
8 ຊົ່ວໂມງກ່ອນ
Amgen vs. Gilead Sciences: Which Biotech Dividend Stock Is the Better Buy?
Techi
·
21 ຊົ່ວໂມງກ່ອນ
Amgen’s IMDELLTRA combo cuts death hazard 58%: AMGN stock forecast
The Motley Fool
·
1 ມື້ກ່ອນ
Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?
MarketWatch
·
1 ມື້ກ່ອນ
Amgen Inc. stock underperforms Friday when compared to competitors
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
About Amgen Inc. BDR
CEORobert A. Bradway
Employees31,5 ພັນ
Founded1980
Headquartersທາວຊັນ ໂອກ, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorBiotechnology
Websiteamgen.com